[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@mickeychiku Mickeychiku

Mickeychiku posts on X about $mist, $nktr, $vktx, $abvx the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

• X Week XXXXXX +209%
• X Month XXXXXX -XXXX%
• X Months XXXXXXX +555%

Mentions: X #

• X Week X -XX%
• X Month XX -XX%
• X Months XXX +196%

Followers: XXX #

• X Week XXX +8.80%
• X Month XXX +17%
• X Months XXX +614%

CreatorRank: XXXXXXXXX #

Social Influence

Social category influence cryptocurrencies XX% stocks XXXX%

Social topic influence $mist #12, $nktr #15, $vktx #28, $abvx #35, $pali #3, $ovid #2, $qure 6.67%, cmc 6.67%, $insm 6.67%, closed XXXX%

Top accounts mentioned or mentioned by @iotaresearch @houndcl @avidresearch @cleanmtnair @junktradeaim

Top assets mentioned Mist (MIST) Viking Therapeutics, Inc (VKTX) uniQure N.V. (QURE) Insmed, Inc. (INSM) BigBear.ai Holdings, Inc. (BBAI) Summit Therapeutics Inc. Common Stock (SMMT) Crinetics Pharmaceuticals, Inc. (CRNX) Sarepta Therapeutics, Inc. (SRPT)

Top Social Posts

Top posts by engagements in the last XX hours

"$Qure Kudos to those who are relentlessly advocating for patients. But BLA can be filed even after negative meeting. Today is last day for FDA to send notes. So Monday should be PR day if company wants to announce. Qure should: - Accept meeting notes - Submit BLA (explaining all trial design issue brought during meeting) - Highlight that clearly on cover letter - This should help bypass RTF (no guarantee) - BLA accepted for scientific review - Negotiate during BLA review (6-12 months) Approval probability is still low but this is the best way to handle this. I think this is what $Repl did"
X Link 2025-11-28T19:46Z XXX followers, 9044 engagements

"$MIST Approved 🎉 Now opens door for another big (1B+) indication in phase X which will be a sBLA labeling supplement with only X months of review. CMC info is same so will be easy approval if phase X hits"
X Link 2025-12-13T01:01Z XXX followers, 6509 engagements

"$INSM Had an opportunity to work for INSM in Sep 2023 but I declined. The RSU value would have been 2M today. Damn"
X Link 2025-11-01T20:23Z XXX followers, 6320 engagements

"2025 Wrap up: C= closed Winners $NKTR (dont care about AA data due to cost basis) $MIST $BBAI (c) $ABVX $SMMT (c) $VKTX (c) $PALI $CTMX (c) $SRPT (c) $CRNX (c) $OVID Losers $RZLT (c) - still hurts losing 450%+ gain. Some big accounts were joining so took risk to go in data. $ALDX - last CRL(c) - fell for questionable PR claims $VYNE (c) - Data gamble There were couple of trades without gain/loss which I havent listed Now to look in 2026 catalyst list"
X Link 2025-12-13T15:13Z XXX followers, 4585 engagements

"$NKTR $ABVX $MIST $VKTX $PALI $OVID For first year newbie bio investors with working experience in biotech what is considered a good %YTD performance in 2025"
X Link 2025-12-15T16:28Z XXX followers, 3756 engagements

"@avidresearch @houndcl Are you planning to hold through approval"
X Link 2025-12-17T17:39Z XXX followers, XX engagements